Shared on17 Aug 25Fair value Increased 5.63%
The upward revision in Apollo Hospitals Enterprise's price target reflects improved profitability, as evidenced by a higher net profit margin and a lower future P/E, resulting in a new consensus fair value of ₹8,587. What's in the News Board meeting scheduled to consider unaudited Q1 FY26 financial results and potential acquisition of Parkway Healthcare's 50% stake in Gleneagles PET-CT Private Limited.
Shared on23 Apr 25Fair value Increased 0.086%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 0.049%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 0.48%
AnalystConsensusTarget has decreased revenue growth from 16.3% to 14.5% and increased profit margin from 9.0% to 10.3%.
Shared on02 Apr 25Fair value Increased 3.09%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Decreased 0.17%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Decreased 3.89%
AnalystConsensusTarget has increased shares outstanding growth rate from 0.0% to 0.0%.